Tipperary firm ups the fight against cancer
11 September, 2019
An oncology drug which is easier to administer to women suffering from ovarian cancer than those currently available on the market is the first of a number of innovative drugs under development at Shorla Pharma in Clonmel, Co Tipperary.
The two-year-old pharmaceutical startup specialises in developing oncology drugs for rare forms of cancer in women and children.
The company is also working on an oral product for paediatric cancer which will be easier for children to swallow than the hard capsules currently used.
Since the setting up of Shorla Pharma in January 2018, the company has raised €2m which has included funding from its founders Sharon Cunningham and Orlaith Ryan as well as from private investment.
For more information click HERE.